Ken Griffin's Citadel reshaped its $900 billion portfolio in the third quarter. It added 2,490 positions and fully exited 2,219 across 13,843 holdings, according to its latest 13F filing.
The firm cut Space Exploration Technologies Corp. (NASDAQ:SPCX) by 94%, Amazon.com Inc. (NASDAQ:AMZN) by 56%, Advanced Micro Devices Inc. (NASDAQ:AMD) by 61% and Apple Inc. (NASDAQ:AAPL) by 37%. It also made deep cuts to AbbVie Inc. (NYSE:ABBV), down 81%, Abbott Laboratories (NYSE:ABT), down 80%, and Chevron Corporation (NYSE:CVX), down 76%.
The largest stake raise, by a wide margin, is Marvell Technology Inc. (NASDAQ:MRVL) at 729%. The fund also boosted Procter & Gamble Company (NYSE:PG) by 189% and Mastercard Incorporated (NYSE:MA) by 161%. Notable new stakes include ARK Innovation ETF (NYSE:ARKK), Rocket Lab Corporation (NASDAQ:RKLB) and FTAI Aviation Ltd. (NASDAQ:FTAI).
The top 10 holdings point to a tightly hedged book. Citadel holds puts and calls on the SPDR S&P 500 ETF Trust (NYSE:SPY), Invesco QQQ Trust (NASDAQ:QQQ) and Micron Technology Inc. (NASDAQ:MU). It also holds calls on Meta Platforms Inc. (NASDAQ:META), NVIDIA Corporation (NASDAQ:NVDA), Advanced Micro Devices Inc. (NASDAQ:AMD) and Apple Inc. (NASDAQ:AAPL).
That positioning paid off in October. The S&P 500 fell nearly 1%. Goldman Sachs prime brokerage data showed Oct. 22 was one of the worst days for hedge funds since COVID-19, Business Insider reported. Even so, Griffin's $77 billion flagship fund gained 1.7%, a person close to the firm told the outlet.
That performance lifted its year-to-date return to 15.3%, the best among multistrategy peers.














